Sign in Subscribe
Cancer research

High Prevalence of Human Papillomavirus (HPV) in Bangladesh Worrying Health Officials

Strategic Insights

— 2 min read

Recent findings from a nationwide cervical and breast cancer screening program have revealed a concerning trend in the prevalence of Human Papillomavirus (HPV) among Bangladeshi women. According to the study, which involved screening over 10,000 women in two upazilas, an average of 4.27% of women in Bangladesh carry the virus that can cause cervical cancer. This suggests that approximately 5 out of every 100 women are infected with HPV. The high prevalence of HPV has led health officials to sound the alarm, emphasizing the need for increased screening and awareness to combat the growing public health concern.

Key Takeaways:

  • The nationwide cervical and breast cancer screening program has detected Human Papillomavirus (HPV) in an average of 4.27% of women screened over the last five years.
  • Approximately 5 out of every 100 women in Bangladesh are infected with HPV, which is a major cause of cervical cancer.
  • High-risk HPV genotyping in cervical cancer screening has shown a 3.2% prevalence of the virus among 10,000 women aged 30 to 60.
  • Among the infected women, 1% had HPV type 16 and 0.2% had type 18.
  • The study concluded that HR-HPV testing is more sensitive than VIA (Visual Inspection with Acetic Acid) for cervical cancer screening.
  • The Health Education and Family Welfare Division at the Ministry of Health and Family Welfare has emphasized the need to integrate screening into the regular health system.
  • Women's health continues to be a neglected area, but with collective support, it is possible to expand screening and research initiatives.
  • Cervical and breast cancer are among the leading causes of death in Bangladeshi women, with diagnosis and treatment being the core goal of healthcare.

Statistics:

  • 4.27% of women in Bangladesh carry Human Papillomavirus (HPV), a major cause of cervical cancer.
  • Approximately 5 out of every 100 women in Bangladesh are infected with HPV.
  • 10,000 women aged 30 to 60 were involved in a pilot study to evaluate the role of high-risk HPV genotyping in cervical cancer screening.
  • 3.2% of women in the study had high-risk HPV (HR-HPV) infections.
  • 1% (97 women) had HPV type 16 infections.
  • 0.2% (20 women) had HPV type 18 infections.
  • HR-HPV testing is 100% sensitive for cervical cancer screening.

Sources:

  • National event held at the Shaheed Abu Sayeed Convention Center of BMU on Sunday.
  • Professor Dr. Ashrafunnesa, director of the population-based cervical and breast cancer screening project.
  • Dr. Asma Akter Sonia, who led a pilot study in two upazilas to evaluate the role of high-risk HPV genotyping in cervical cancer screening.
  • Dr. Md. Sarwar Bari, secretary of the Health Education and Family Welfare Division at the Ministry of Health and Family Welfare.

Read more